Recent topics on endoscopic ultrasonography-guided celiac plexus neurolysis
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Endoscopic ultrasonography-guided celiac plexus neurolysis (EUS-CPN) is a widely practiced technique. Three sets of guidelines have recently been published and this procedure has become a major EUS technique. However, there are still several unanswered questions. The purpose of this manuscript is to review the recent literature pertaining to EUS-CPN. Currently, the main indication of EUS-CPN is pancreatic cancer pain. It is also performed for patients with chronic pancreatitis, but the indication is controversial due to its limited efficacy and a high incidence of infectious complications. Various techniques, such as central and bilateral EUS-CPN, and EUS-guided direct celiac ganglia neurolysis (EUS-CGN) have been performed. However, the efficacies of these techniques remain controversial. Complications related to the procedures are generally not serious, but major adverse events, such as paraplegia and ischemic complications, have been reported. The impacts of EUS-CPN on survival have also been evaluated. Although increased survival was expected via improvements in the quality of life, data suggests that EUS-CPN related procedures, especially EUS-CGN, might reduce the survival time. However, precise mechanisms have not been elucidated. In addition to conventional techniques, new techniques, such as EUS-guided celiac ganglion radiofrequency ablation (EUS-RFA) and the use of highly viscous phenol-glycerol, dexmedetomidine, and contrast-enhanced agents, have been introduced. However, these techniques are still in experimental stages. Additional studies need to be conducted to address these gaps in the literature.
Abstract
Endoscopic ultrasonography-guided celiac plexus neurolysis (EUS-CPN) is a widely practiced technique. Three sets of guidelines have recently been published and this procedure has become a major EUS technique. However, there are still several unanswered questions. The purpose of this manuscript is to review the recent literature pertaining to EUS-CPN. Currently, the main indication of EUS-CPN is pancreatic cancer pain. It is also performed for patients with chronic pancreatitis, but the indication is controversial due to its limited efficacy and a high incidence of infectious complications. Various techniques, such as central and bilateral EUS-CPN, and EUS-guided direct celiac ganglia neurolysis (EUS-CGN) have been performed. However, the efficacies of these techniques remain controversial. Complications related to the procedures are generally not serious, but major adverse events, such as paraplegia and ischemic complications, have been reported. The impacts of EUS-CPN on survival have also been evaluated. Although increased survival was expected via improvements in the quality of life, data suggests that EUS-CPN related procedures, especially EUS-CGN, might reduce the survival time. However, precise mechanisms have not been elucidated. In addition to conventional techniques, new techniques, such as EUS-guided celiac ganglion radiofrequency ablation (EUS-RFA) and the use of highly viscous phenol-glycerol, dexmedetomidine, and contrast-enhanced agents, have been introduced. However, these techniques are still in experimental stages. Additional studies need to be conducted to address these gaps in the literature.
참고문헌 (32)
- Faigel DO, "Endosonography-guided celiac plexus injection for abdominal pain due to chronic pancreatitis", Am J Gastroenterol, 91, pp.1675~ (1996)
- Wiersema MJ, "Endosonography-guided celiac plexus neurolysis", Gastrointest Endosc, 44, pp.656~662 (1996)
- Yasuda I, "Endoscopic ultrasound-guided celiac plexus block and neurolysis", Dig Endosc, 29, pp.455~462 (2017)
- Teoh AYB, "Consensus guidelines on the optimal management in interventional EUS procedures : results from the Asian EUS group RAND", UCLA expert panel, 2018, pp.67, 1209~1228
- Sey MS, "Effectiveness and safety of serial endoscopic ultrasound-guided celiac plexus block for chronic pancreatitis", Endosc Int Open, 3, pp.E56~9 (2015)
- Alhazzani W, "Chronic abdominal pain secondary to mesenteric panniculitis treated successfully with endoscopic ultrasonography-guided celiac plexus block : a case report", World J Gastrointest Endosc, 7, pp.563~566 (2015)
- Sakamoto H, "EUS-guided broad plexus neurolysis over the superior mesenteric artery using a 25-gauge needle", Am J Gastroenterol, 105, pp.2599~2606 (2010)
- Levy MJ, "Initial evaluation of the efficacy and safety of endoscopic ultrasound-guided direct Ganglia neurolysis and block", Am J Gastroenterol, 103, pp.98~103 (2008)
- Puli SR, "EUS-guided celiac plexus neurolysis for pain due to chronic pancreatitis or pancreatic cancer pain : a meta-analysis and systematic review", Dig Dis Sci, 54, pp.2330~2337 (2009)
- Kaufman M, "Efficacy of endoscopic ultrasound-guided celiac plexus block and celiac plexus neurolysis for managing abdominal pain associated with chronic pancreatitis and pancreatic cancer", J Clin Gastroenterol, 44, pp.127~134 (2010)
- Iwata K, "Predictive factors for pain relief after endoscopic ultrasound-guided celiac plexus neurolysis", Dig Endosc, 23, pp.140~145 (2011)
- LeBlanc JK, "A prospective, randomized study of EUS-guided celiac plexus neurolysis for pancreatic cancer: one injection or two?", Gastrointest Endosc, 74, pp.1300~1307 (2011)
- Téllez-Ávila FI, "Central is as effective as bilateral endoscopic ultrasound-guided celiac plexus neurolysis in patients with unresectable pancreatic cancer", Endosc Ultrasound, 2, pp.153~156 (2013)
- Lu F, "Bilateral vs. unilateral endoscopic ultrasound-guided celiac plexus neurolysis for abdominal pain management in patients with pancreatic malignancy: a systematic review and metaanalysis", Support Care Cancer, 26, pp.353~359 (2018)
- Doi S, "Endoscopic ultrasound-guided celiac ganglia neurolysis vs. celiac plexus neurolysis: a randomized multicenter trial", Endoscopy, 45, pp.362~369 (2013)
- Ascunce G, "EUS visualization and direct celiac ganglia neurolysis predicts better pain relief in patients with pancreatic malignancy(with video)", Gastrointest Endosc, 73, pp.267~274 (2011)
- Minaga K, "Predictors of pain response in patients undergoing endoscopic ultrasound-guided neurolysis for abdominal pain caused by pancreatic cancer", Therap Adv Gastroenterol, 9, pp.483~494 (2016)
- Levy MJ, "Combined celiac ganglia and plexus neurolysis shortens survival, without benefit, vs plexus neurolysis alone", Clin Gastroenterol Hepatol, 17, pp.728~738.e9 (2019)
- Kappelle WFW, "EUSguided celiac ganglia neurolysis : a clinical and human cadaver study(with video)", Gastrointest Endosc, 86, pp.655~663 (2017)
- Facciorusso A, "Sarcopenia represents a negative prognostic factor in pancreatic cancer patients undergoing EUS celiac plexus neurolysis", Endosc Ultrasound, 9, pp.238~244 (2020)
- Kanno Y, "Efficacy of EUS-guided celiac plexus neurolysis compared with medication alone for unresectable pancreatic cancer in the oxycodone", fentanyl era : a prospective randomized control study, 2020, pp.92, 120~130
- Facciorusso A, "Response to repeat echoendoscopic celiac plexus neurolysis in pancreatic cancer patients : a machine learning approach", Pancreatology, 19, pp.866~872 (2019)
- Minaga K, "Acute spinal cord infarction after EUS-guided celiac plexus neurolysis", Gastrointest Endosc, 83, pp.1039~1040 (2016)
- Fujii-Lau LL, "Impact of celiac neurolysis on survival in patients with pancreatic cancer", Gastrointest Endosc, 82, pp.46~56.e2 (2015)
- Manta R, "A multimodal, one-session endoscopic approach for management of patients with advanced pancreatic cancer", Surg Endosc, 30, pp.1863~1868 (2016)
- Ishiwatari H, "EUS-guided celiac plexus neurolysis by using highly viscous phenol-glycerol as a neurolytic agent(with video)", Gastrointest Endosc, 81, pp.479~483 (2015)
- Saleh AAG, "Value of adding dexmedetomidine in endoscopic ultrasound-guided celiac plexus neurolysis for treatment of pancreatic cancer-associated pain", J Gastrointest Cancer (2020)[DOI]
- Facciorusso A, "Echoendoscopic ethanol ablation of tumor combined to celiac plexus neurolysis improved pain control in a patient with pancreatic adenocarcinoma", Endosc Ultrasound, 4, pp.342~344 (2015)
- Bang JY, "EUS-guided celiac ganglion radiofrequency ablation versus celiac plexus neurolysis for palliation of pain in pancreatic cancer : a randomized controlled trial(with videos)", Gastrointest Endosc, 89, pp.58~66.e3 (2019)
- Wang L, "Contrast-enhanced ultrasoundguided celiac plexus neurolysis in patients with upper abdominal cancer pain : initial experience", Eur Radiol, 30, pp.4514~4523 (2020)
- Fusaroli P, "EFSUMB guidelines on Interventional Ultrasound(INVUS), Part V", Ultraschall Med, 37, pp.77~99 (2016)
- Wyse JM, "Practice guidelines for endoscopic ultrasound-guided celiac plexus neurolysis", Endosc Ultrasound, 6, pp.369~375 (2017)